2-Furancarboxylic acid, 5-[3-[(2Z)-2-[1,5-dihydro-3-methyl-5-oxo-1-(5,6,7,8-tetrahydro-2-naphthalenyl)-4H-pyrazol-4-ylidene]hydrazinyl]-2-hydroxyphenyl]-

2-Furancarboxylic acid, 5-[3-[(2Z)-2-[1,5-dihydro-3-methyl-5-oxo-1-(5,6,7,8-tetrahydro-2-naphthalenyl)-4H-pyrazol-4-ylidene]hydrazinyl]-2-hydroxyphenyl]- 구조식 이미지
카스 번호:
1257792-41-8
상품명:
2-Furancarboxylic acid, 5-[3-[(2Z)-2-[1,5-dihydro-3-methyl-5-oxo-1-(5,6,7,8-tetrahydro-2-naphthalenyl)-4H-pyrazol-4-ylidene]hydrazinyl]-2-hydroxyphenyl]-
동의어(영문):
SHR8735;SHR-8735;SHR 8735;HetrombopagEthanolamine;Hetrombopag Ethanolamine;2-Furancarboxylic acid, 5-[3-[(2Z)-2-[1,5-dihydro-3-methyl-5-oxo-1-(5,6,7,8-tetrahydro-2-naphthalenyl)-4H-pyrazol-4-ylidene]hydrazinyl]-2-hydroxyphenyl]-
CBNumber:
CB75486879
분자식:
C25H22N4O5
포뮬러 무게:
458.47
MOL 파일:
1257792-41-8.mol

2-Furancarboxylic acid, 5-[3-[(2Z)-2-[1,5-dihydro-3-methyl-5-oxo-1-(5,6,7,8-tetrahydro-2-naphthalenyl)-4H-pyrazol-4-ylidene]hydrazinyl]-2-hydroxyphenyl]- 속성

끓는 점
669.3±65.0 °C(Predicted)
밀도
1.47±0.1 g/cm3(Predicted)
용해도
DMSO:0.0(Max Conc. mg/mL);0.0(Max Conc. mM)
산도 계수 (pKa)
-1.35±0.40(Predicted)

안전

2-Furancarboxylic acid, 5-[3-[(2Z)-2-[1,5-dihydro-3-methyl-5-oxo-1-(5,6,7,8-tetrahydro-2-naphthalenyl)-4H-pyrazol-4-ylidene]hydrazinyl]-2-hydroxyphenyl]- C화학적 특성, 용도, 생산

2-Furancarboxylic acid, 5-[3-[(2Z)-2-[1,5-dihydro-3-methyl-5-oxo-1-(5,6,7,8-tetrahydro-2-naphthalenyl)-4H-pyrazol-4-ylidene]hydrazinyl]-2-hydroxyphenyl]- 준비 용품 및 원자재

원자재

준비 용품


2-Furancarboxylic acid, 5-[3-[(2Z)-2-[1,5-dihydro-3-methyl-5-oxo-1-(5,6,7,8-tetrahydro-2-naphthalenyl)-4H-pyrazol-4-ylidene]hydrazinyl]-2-hydroxyphenyl]- 공급 업체

글로벌( 4)공급 업체
공급자 전화 이메일 국가 제품 수 이점
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Artis Biotech Co. Ltd. 19138486554 18582380095
sales@artisbio.com China 3066 58
Hebei Weite Medical Technology Co., Ltd 13180081292
contact@wetogethermed.com China 7280 58
TargetMol Chemicals Inc. 4008200310
marketing@tsbiochem.com China 24131 58

Copyright 2019 © ChemicalBook. All rights reserved